
The World Health Organization March 17 said the benefits of the Oxford-AstraZeneca vaccine outweigh its risks and recommended that its vaccinations continue. Several European Union countries have temporarily suspended use of the novel coronavirus disease (COVID-19) vaccine as a precautionary measure based on reports of rare blood coagulation disorders in persons who had received the vaccine.